Chemours reports narrower second-quarter loss as cash flow improves

Wilmington, DE – The Chemours Co. reported a narrower second-quarter loss Tuesday as higher pricing across its businesses helped offset weaker volumes in several product categories.

The chemical manufacturer reported net sales of $1.59 billion for the quarter ended June 30, down about 1% from $1.62 billion during the same period a year earlier. The company posted a net loss attributable to shareholders of $274 million, or $1.81 per diluted share, compared with a loss of $380 million, or $2.53 per share, in the second quarter of 2025.

Adjusted net income totaled $64 million, or 42 cents per diluted share, compared with $91 million, or 61 cents per share, a year earlier. Adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, fell to $247 million from $260 million.

Chemours Chief Executive Denise Dignam said the company delivered results near the upper end of its guidance range despite what she described as a challenging economic environment.

The company said improved pricing in its Titanium Technologies business and increased demand for specialty products used in data centers and semiconductor applications contributed to results. Free cash flow rose 128% year over year to $114 million, while the company’s net leverage ratio declined to approximately 4.4 times adjusted EBITDA.

Within the company’s Thermal & Specialized Solutions segment, sales slipped 1% to $591 million. Revenue from Opteon refrigerants fell 10%, while Freon refrigerant sales increased 22%. Segment adjusted EBITDA rose 3% to $213 million.

Titanium Technologies posted sales of $661 million, up 1% from the prior-year period, while adjusted EBITDA increased to $48 million from $47 million. The company attributed the gains primarily to higher global pricing.

Sales in the Advanced Performance Materials division fell 6% to $326 million. However, revenue from the segment’s Performance Solutions business increased 8% as demand strengthened among data center and semiconductor customers. Adjusted EBITDA for the segment declined 48% to $26 million.

Chemours said it ended the quarter with approximately $671 million in unrestricted cash and cash equivalents and total liquidity of about $1.6 billion. During the quarter, the company repaid €230 million of debt using proceeds from a previously announced land sale and internally generated cash.

Looking ahead, Chemours said it expects third-quarter sales to range from flat to down 5% on a sequential basis and forecast adjusted EBITDA of between $175 million and $205 million. For the full year, the company maintained its expectation of revenue growth between 1% and 5% and adjusted EBITDA of $775 million to $825 million.